Molecular imaging of vesicular acetylcholine transporter (VAChT) in the brain provides an important cholinergic biomarker for the pathophysiology and treatment of dementias including Alzheimer's disease. In this study, kinetics modeling methods were applied and compared for quantifying regional brain uptake of the VAChT-specific positron emission tomography radiotracer, ((À)-(1-(-8-(2-fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)-methanone) ([ 18 F]VAT) in macaques. Total volume distribution (V T ) estimates were compared for one-tissue compartment model (1TCM), two-tissue compartment model (2TCM), Logan graphic analysis (LoganAIF) and multiple linear analysis (MA1) with arterial blood input function using data from three macaques. Using the cerebellum-hemispheres as the reference region with data from seven macaques, three additional models were compared: reference tissue model (RTM), simplified RTM (SRTM), and Logan graphic analysis (LoganREF). Model selection criterion indicated that a) 2TCM and SRTM were the most appropriate kinetics models for [ 
Loss of cholinergic neurons and synapses contributes to progressive cognitive dysfunction in Alzheimer's disease (AD), Parkinson disease (PD), and Huntington disease (HD) (Bohnen et al. 2003; Pirker et al. 2003; Braak et al. 2004; Bohnen and Albin 2011; Ransome and Hannan 2012) . Vesicular acetylcholine transporter (VAChT), predominantly found in pre-synaptic terminal vesicles, is responsible for loading newly synthesized acetylcholine from the cytoplasm into pre-synaptic vesicles. VAChT provides a reliable biomarker for cholinergic neurons under normal (Efange 2000; Haense et al. 2012; Prado et al. 2013 ) and neurodegenerative conditions (Bohnen et al. 2009; Bohnen and Albin 2011) . Recent immunohistochemistry evidence found that VAChT and a-synuclein, a distinctive hallmark of PD, are co-expressed in cholinergic axons and involved in the fusion of vesicles with the pre-synaptic membrane (Sharrad et al. 2013a,b) . These studies suggest that VAChT might play a pivotal role in neurodegeneration. Concordantly, positron emission tomography (PET) imaging with a suitable VAChT-specific radiotracer that can assess the loss of cholinergic synapses or neurons would provide a useful tool for determining the severity of neurodegenerative diseases.
Vesamicol [(À)-2-(4-phenylpiperidino) cyclohexanol] was identified decades ago as a lead ligand for VAChT (Anderson et al. 1986 ). Because of its cross reactivity with r 1/2 receptors in the brain, initial efforts focused on optimizing the structures of vesamicol analogs to increase selectivity for r 1/2 receptors, and to improve in vivo kinetics and metabolic stability (Efange 2000; Kawamura et al. 2006; Tu et al. 2009 Tu et al. , 2012 Wang et al. 2011; Li et al. 2013 ). The first FDA-approved VAChT radiotracer, (À)-5-[ (Kulh et al. 1994) , was successfully applied to assess cholinergic deficiency in patients with AD and PD dementia using singlephoton emission computed tomography, (SPECT); PD patients without dementia showed selectively reduced binding of [123I] IBVM in parietal and occipital cortex, whereas PDD and AD patients had more globally reduced cortical binding (Kuhl et al. 1996) . Slow binding kinetics required a scan for approximately 6-h post-injection Giboureau et al. 2007; Barret et al. 2008; Mazere et al. 2013) . Nishiyama et al. (2014) (Nishiyama et al. 2014) . However, it still bound to r 1/2 receptors with nanomolar affinity, resulting in only 10-fold selectivity for VAChT versus r 1/2 receptors (Kawamura et al. 2006; Shiba et al. 2006) . Furthermore, the short half-life of carbon-11 (20.4 min) also obliged producing the tracer on site, which limited its applications for data acquisition over longer time periods. Koeppe and colleagues optimized the structure of IBVM to include a fluorine-18 label, yielding (-) (Giboureau et al. 2007; Kilbourn et al. 2009; Cyr et al. 2014) , as well as in healthy human volunteers (Petrou et al. 2014) . PET Studies using [ 18 F]-FEOBV in rat models of cholinergic deficits and in AD patients reported decreased tracer uptake in brain regions that had cholinergic neuron terminal losses and/or related with AD pathologies (Parent et al. 2012 (Parent et al. , 2013 Cyr et al. 2014 Cyr et al. , 2015 Aghourian et al. 2017) . However, the slow kinetics required scans over 360 min for full compartmental kinetics analysis (Cyr et al. 2014; Petrou et al. 2014) .
Our group has developed a new class of VAChT selective inhibitors having a carbonyl group interposed between an aromatic ring and the piperidine ring; these compounds have high affinity to VAChT with K i values less than 10 nM, and the selectivity for VAChT versus r 1/2 receptors over thousands fold (Tu et al. 2009 (Tu et al. , 2012 Efange et al. 2010; Wang et al. 2011; Li et al. 2013) . We initially reported the in vivo specificity, and tracer kinetics of (À)-[ 11 C]TZ659 (Jin et al. 2016) . To overcome the limitation of the short half-life of the carbon-11 isotope, we subsequently developed an F-18 labeled analog, ((À)-(1-(-8-(2-fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl) piperidin-4-yl)(4-fluoro-phenyl)-methanone) ([ 18 F]VAT) with a K i value of 0.59 nM, and with over 10 000-fold selectivity for VAChT versus r 1/2 receptors . Recently we have reported automated production of [ 18 F] VAT in a Current Good Manufacturing Practice (cGMP) cyclotron facility ) and the whole-body PET studies in NHPs for human dosimetry estimates (Karimi et al. 2015) . These studies collectively suggest that [ 18 
F]
VAT is a promising radiopharmaceutical for imaging VAChT in vivo (Li et al. 2013; Karimi et al. 2015; Tu et al. 2015; Yue et al. 2016 
Materials and methods

Radiochemistry and chemicals
The synthesis and the radiolabeling of [ 18 F]VAT were accomplished as previously described Yue et al. 2016) . The radiochemical yield was 30-40% (decay corrected to end of synthesis) with a radiochemical purity > 99%, chemical purity > 95%, and mean-specific activity > 63 GBq/lmol (n > 30, decay corrected to end of synthesis).
Non-human primate subjects Seven male cynomolgus macaques (NCBI_Taxon:9541, Age: 6.9 AE 0.7 years, weight: 8.0 AE 1.5 kg, mean AE SD) were used for PET imaging studies, and the detail information of each macaque is summarized in Table 1 . All procedures regarding the study design, animal experiments, statistical analysis, and data reporting fulfill the criteria of the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines (http://www.nc3rs.org.uk/page.asp?id=1357). Predetermined sample size was not calculated. No randomization was performed. PET data from animals which did not complete the entire 120-min scan or had head movement during the study was excluded. No animals were excluded. All animal experiments were conducted in compliance with the Guidelines for the Care and Use of Research Animals under protocols approved by the Animal Studies Committee of Washington University School of Medicine in St. Louis. The study was not pre-registered. MRI, PET scans, and data acquisition are detailed in the method section. The arterial blood samples of subject A -C were collected for radioactive metabolite analysis during PET scans. Subjects D -G underwent baseline scans without collecting blood samples (Table 1) . For the test-retest reproducibility studies within the same subject and among different subjects, subjects A-C underwent at least two PET imaging scans under baseline condition. For the same animal, the interval between scans was at least 2 weeks. In addition, a blocking study was done in subject A by i.v. administration of (À)-vesamicol (0.125 mg/ kg) about 5 min prior to the injection of [ 
MRI scans
For MRI scans, animals were initially anesthetized with ketamine at a dose of 10-20 mg/kg via intramuscular (i.m.) injection and glycopyrrolate at a dose of 0.13-0.017 mg/kg via i.m. injection, and intubated with an endotracheal tube under anesthesia, maintained at a dose of 0.75-2.0% isoflurane in oxygen throughout the procedure. MR images were acquired for each animal on a 3.0-T Trio or Prisma scanner (Siemens Medical Solutions, Malvern PA, USA), using an 8-channel knee coil. The animal was positioned supine in a custom-made animal holder and stabilized with padding around the head. Rectal temperature was maintained within normal physiological range (37-38°C) using a custom-built warm-air blanket. End-tidal O 2 saturation, body temperature, heart rate, and respiration rate were maintained within normal physiologic ranges and continuously monitored using MRI compatible physiological monitoring equipment (Precess; InVivo, Orlando, FL, USA). Each NHP subject had the baseline MRI scan with a magnetization-prepared rapid acquisition gradient echo sequence: repetition time = 2400 ms, echo time = 3.93 ms, inversion time = 1100 ms, FOV = 154 mm, flip angle = 8°, 208 sagittal slices, voxel size = 0.8 9 0.8 9 0.8 mm. The MR image volume was then cropped to 176 9 176 9 176 pixels and re-oriented into coronal slices using the Analyze 12.0 software (AnalyzeDirect Inc., Overland Park, KS, USA) for coregistration with PET images.
MicroPET imaging scans and data process A microPET Focus 220 scanner (Concorde/CTI/Siemens Microsystems, Knoxville, TN, USA) was used for the acquisition of imaging data for [ 18 F]VAT. For PET scans, animals were fasted for 12 h before each scan, initially anesthetized with ketamine at a dose of 10-20 mg/kg i.m. and glycopyrrolate at dose of 0.13 mg/kg i.m. and fitted with an endotracheal tube under anesthesia, maintained at 0.75-2.0% isoflurane in oxygen throughout the procedure. After intubation, a percutaneous venous catheter was placed for radiotracer injection. A 20-gauge plastic catheter was inserted into a femoral artery to permit arterial blood sampling. Blood pressure and pulse were monitored throughout the scan. Vital signs were monitored every 15 min, and core temperature was kept constant at 37°C with heated water blankets. The head of the animal was positioned with the aid of a laser fixed within the PET scanning aperture. The head was firmly positioned with padding inside a modified head holder. In each microPET scan session, the head was positioned supine in the adjustable head holder with the brain in the center of the field of view. Attenuation characteristics of the head were determined individually prior to each study by obtaining a transmission scan. After that, the animal was administrated 378 AE 33 MBq (mean AE SD) of [ 18 F]VAT via the venous catheter. Subsequently, a 120-min dynamic emission scan (3 9 1-min, 4 9 2-min, 3 9 3-min, and 20 9 5-min frames) was acquired.
The resolution of the reconstructed PET image was < 2.0 mm full width at half maximum for all three dimensions at the center of the field of view (Tai et al. 2005) . Emission scans were corrected using individual attenuation and model-based scatter correction and reconstructed using filtered back projection as described previously (Miller et al. 1989) . The first baseline PET image for each animal acted as the target image with the MRI (MP-RAGE) and subsequent PETs coregistered to it using an automated image registration program automated image registration (AIR) (Woods et al. 1993; Tabbal et al. 2006) . For quantitative analyses, two-dimensional regions of interest (cerebellar hemispheres, vermis, frontal cortex, occipital cortex, temporal cortex, striatum including caudate and putamen, white matter, midbrain, and hippocampus) were drawn based on multiple lays of MRI brain images following the standard protocol, and transformed to the volume of interest (VOI) in Analyze 12.0 software (AnalyzeDirect Inc., Lexana, KS, USA) Jin et al. 2016) . The VOIs were transformed to the baseline PET space and then overlaid on all reconstructed PET images to obtain tissue time-activity curves in a homemade program Vidi Jin et al. 2016) . Radioactivity measures were standardized to body weight and dose of radioactivity injected to yield standardized uptake value (SUV).
Whole blood and plasma collection for arterial blood input function
To determine the radioactive metabolite for correction of the arterial input function, arterial blood samples were collected from the F] VAT. Continuous and sequential discrete arterial blood samples were collected during the first 2 min using an automated system with a peristaltic pump that pulls arterial blood through a radioactivity detector composed of a plastic scintillator as we previously published (Jin et al. 2016) . Additional arterial samples (2-3 mL) were collected in heparinized syringes manually at 2, 5, 10, 15, 30, 60, 90, and 120 min after tracer injection for measurements of radiolabeled metabolites. High-performance liquid chromatography (HPLC) radioactive metabolite analysis followed our published protocol (Jin et al. 2016) . The percentiles of the plasma in whole blood (~60-70%) determined from the samples collected manually (2-120 min) were used to correct the plasma radioactivity curve for automatic sampling (0-2 min). The percentile of unmetabolized [ 18 F]VAT in the manually collected samples was determined from HPLC radioactive metabolite analysis. A metabolite-corrected plasma curve was used as input function [Cp(t)] for the kinetics and graphics analysis in a Matlab program (MathWorks Inc., Natick, MA, USA).
Radio-metabolite analysis using HPLC Radioactivity in whole blood (1 mL) was counted in a well gamma counter (Beckman Instruments Inc., Fullerton, CA, USA), then centrifuged at 2500 g in an Eppendorf 5415C centrifuge (Eppendorf North America, Inc., Westbury NY, USA) for 5 min to separate red blood cells from plasma. Portions of plasma (400 lL) were solventdeproteinated using 0.92 mL ice-cold methanol and separated by centrifugation for 3 min at 2500 g. The supernatant of the centrifuged blood sample was mixed with water (1/1, v/v) and 180 lL of mixture was injected into a HPLC system for determination of radioactive metabolites. The HPLC system consisted of an Agilent SB C-18 analytic HPLC column (250 9 4.6 mm, 5 lm) and a UV detector with wavelength set at 254 nm. The mobile phase was composed of acetonitrile/0.1 M ammonium formate buffer (48/52, v/v, pH 4.5), and the flow rate was 1.0 mL/min. The HPLC fractions were collected at 1 min intervals for 16 min; each fraction was counted using a well gamma counter to determine the radioactivity. The results were corrected for background radiation and physical decay. The sample recovery yield, extraction efficiency, and HPLC fraction recovery were calculated by measuring radioactivity in the plasma HPLC fractions. The plasma parent fraction was determined as the ratio of the radioactivity of the parent (standard) compound to the total plasma amount of radioactivity collected.
Modeling methods
To quantitatively assess the radiotracer transfer between plasma, brain, and VAChT, seven different model-based kinetics methods were performed in this study (Logan et al. 1990 (Logan et al. , 1994 Ichise and Ballinger 1996; . Four of these seven methods need arterial blood sampling for blood input correction and they were the one-tissue compartment model (1TCM), two-tissue compartment model (2TCM), Logan graphic analysis (LoganAIF) and multiple linear analysis (MA1). The remaining three methods were based on reference modeling and they were the reference tissue model (RTM), simplified reference tissue model (SRTM), and Logan graphic analysis (LoganREF). Total volume distribution (V T ), distribution volume ratio (DVR), the non-displaceable binding potential (BP ND ) and other parameters were calculated accordingly. To establish the time dependence of BP ND estimates, The BP ND in the striatum was calculated by SRTM and LoganREF using entire 120-min recordings, and with truncation to 90, 60, 45 mins, and always with exclusion of the first 20 mins from the Logan linearization.
In the regression, the fits were performed with optimization of Chisquare (v 2 ), which was the sum of the squared discrepancies between data and model predictions divided by the number of degrees of freedom. The cycle of v 2 calculation and parameter adjustment was repeated until further reduction of v 2 was not possible. The final set of parameters was regarded as the best-fit result. The independence of parameters was also assessed by a standard error (SE) via examining the covariance of the parameter (Gavin 2016) . All non-linear regression modeling was solved by non-linear least square fitting using the Marquart-Levenberg algorithm implemented in the Matlab function lm.m (Gavin 2016 ) (MathWorks Inc., Natick, MA, USA). Relative standard error (rSE), which equals the SE value divided by the mean value, was also calculated to reveal the reliability of the estimation of each parameter. In addition, the Lassen plot (Cunningham et al. 2010 ) was used to estimate non-displaceable distribution volume (V ND ) of [ 
Model comparison and correlation analysis
Goodness-of-fit for seven modeling methods were compared using model selection criterion (MSC) (Fujita et al. 1999) which was a simplified version applied to PET data analysis based on the original concept of Akaike information criterion (AIC) (Akaike 1974 ). The preferred model is the one with the highest MSC value. The value of v 2 also provided a useful measure of goodness-of-fit. If the model described the measured data, the value of v 2 would mostly represent the variance of the data and were close to 0. Regarding the correlation of these modeling methods, Pearson correlation was performed according to the procedure in the statistics section below.
Test-retest reproducibility studies
The BP ND values from the model fitting of the SRTM and LoganREF were applied for the test-retest reproducibility. The testretest study was performed with three NHP subjects A, B, and C (Table 1) to evaluate the variability in the relevant outcome for BP ND . Each subject was studied twice, for which the physiology of the NHP and experimental conditions were identical. The test-retest variability (TRV) was then calculated for each region as follows:
Intraclass correlation coefficient (ICC) also was calculated as follows:
where MSBSS and MSWSS were the mean sum of squares between and within subjects, respectively; n was the number of withinsubject measurements, in this study, n = 3. ICC was the ratio of between-subject variances to total variance and the appropriate metric for assessing within-subject reliability. Therefore, ICC values were particularly high if within-subject (i.e. within-subject between sessions) variance was high.
Statistics
For modeling method comparison, the F-test (Hawkins et al. 1986 ) provided a comparison of the goodness-of-fit in striatum across all models. A p value of greater than 0.05 indicates that the PET data and the modeling data are not significantly different. Regarding the correlation of these modeling methods, Pearson correlation between BP ND calculated with different brain regions using various models were analyzed to calculate Pearson's coefficients (r), and the p-value was obtained using Prism software (GraphPad Software Inc., LaJolla, CA, USA). In addition, t-test was used to determine the difference in test and retest values. A p value of less than 0.05 indicates statistically significant difference.
Results
TAC of unmetabolized parental [
18 F]VAT from NHP plasma samples HPLC analysis of plasma samples from baseline scans of three NHP subjects revealed that over 60% of the total radioactivity was the parent [ 18 F]VAT in plasma and~40% of the total radioactivity in plasma was attributed to polar metabolites after 20 min p.i. of the radiotracer. Based on our previous analysis, the radioactive metabolites were significantly more polar than the parent compound . Therefore, radioactive metabolites do not likely penetrate the blood-brain barrier and enter into the brain . The percentile of unmetabolized parental [ 18 F]VAT in plasma decreased throughout the time course, from 96 AE 1% at 2 min, to 14 AE 2.7% at 90-min post-injection, respectively, as shown in Fig. 1(c) . Although the actually structure was not confirmed by LC-MS, the rebuilding HPLC fraction collection radiochromatogram indicate the retention time of the major radioactive metabolite was 2-4 min compared to the retention time of 9-11 min for the parent compound [
18 V]VAT, suggesting the major metabolite does not have the capability in crossing the blood-brain barrier and entering into the brain . The average TAC curves were obtained from three subjects for the parental compound [
18 F]VAT in plasma and in the brain regions (Fig. 1b) . The top part of Fig. 1(b) showed that the concentration of parental compound [
18 F]VAT in plasma peaked less than 1-min post-injection, and then rapidly washed out, but the specific binding to the brain regions peaked and then maintained.
Tracer kinetics analysis with different modeling Radiotracer [ 18 F]VAT readily entered the brain and heterogeneously distributed. PET imaging data from the summed images of the dynamic scan from 0 to 120 min in animals at baseline condition are depicted in Fig. 1 . The striatum has the highest accumulation of [ 18 F]VAT, followed by thalamus, hippocampus, frontal cortex, and cerebellum. Characterization of the tracer kinetics (in striatum and other brain regions) with different modeling methods including 2TCM, 1TCM, MA1 (Fig. 2) and LoganAIF with arterial blood input function, and RTM, SRTM, and LoganREF with the reference region as input function were performed for 0-120 min dynamic scans of [
18 F]VAT in three subjects. The modeling results are summarized in Table 2 . The BP ND values were consistent across all these modeling methods with small standard deviation (SD), whereas the V T values showed larger intra-subject variations and SD values shown in Table 2 , suggesting BP ND was more consistent than V T in these estimations.
For the modeling of striatal kinetics with arterial blood input function, including 2TCM, 1TCM, LoganAIF and MA1, based on the MSC, v 2 and F-test p-values, the 2TCM and LoganAIF models proved more appropriate than the 1TCM or MA1 models (Table 2 and Fig. 2) . The baseline kinetics of striatum was also estimated using the referencebased models in total seven NHPs, as shown in Tables 2  and 4 . For the reference-based modeling methods, RTM, SRTM, and LoganREF models, all provided appropriate fittings. Overall, the 2TCM model is most appropriate among the methods with arterial blood input function, and the SRTM model is most appropriate among the methods based on reference without blood input, as shown in Table 2 .
Using the 2TCM method, the tracer kinetics for different brain regions were characterized and summarized in Table 3 . The 2TCM method offered reasonable calculations of K 1 , k 2 , k 3 and k 4 values, but the small values of k 3 and k 4 , led to large SDs of these parameter estimates. As a consequence, values of V T were highly variable between subjects. The rank of V T values (mL/cm 3 ) from high to low were as follows: striatum, thalamus, hippocampus, frontal cortex, vermis, occipital cortex, temporal cortex, white matter, midbrain and cerebellum-hemispheres. Although the V T showed large SD, the BP estimated from k 3 /k 4 ratios was less variable between subjects. Values of k 3 /k 4 estimated are also summarized in Table 3 . The rank of values from high to low is: striatum, thalamus, hippocampus, frontal cortex, vermis, occipital cortex, temporal cortex, white matter, midbrain, and cerebellum-hemispheres. Compared to V T or k 3 /k 4 , the BP ND (DVR-1) values were estimated with the smallest SD. And the rank order of BP ND values are consistent with the rank order of VAChT density in brain regions. At baseline conditions, the highest BP ND (DVR-1) value (mean AE SD) was observed in the striatum (3.37 AE 0.34), intermediate levels were observed in thalamus (1.16 AE 0.24), hippocampus (0.61 AE 0.41), frontal cortex (0.44 AE 0.10) and vermis (0.22 AE 0.55) regions, and lowest BP ND values were observed in the white matter (0.21 AE 0.13) and cerebellum-hemispheres. This is consistent with literature reports that these regions have relatively lower expression of VAChT (Weihe et al. 1996; Efange 2000; Efange et al. 2000) .
To estimate the V ND of [ 18 F]VAT and to further verify the suitability of cerebellar hemispheres as the reference region, the data from a blocking study using a VAChT-specific inhibitor (À)-vesamicol (0.125 mg/kg) and one baseline scan from the same monkey (subject A) was analyzed. The result showed partial blockade was achieve by~54% and the V ND was~1.27, which was slightly lower than the V T value of cerebellar hemispheres (Fig. 3) . Because of the inaccuracy in quantification in low binding regions, the difference may be overestimated. As a result, cerebellar hemispheres is suitable as the reference region for [ 18 F]VAT kinetic modeling analysis using reference-based methods.
Using the reference-based method, different brain regions other than cerebellum-hemispheres were characterized and summarized in Table 4 . Both SRTM and LoganREF provided heterogeneous binding profiles for the different brain regions, as did 2TCM. The rank of the specific binding from LoganREF (Fig. 4) was: striatum > thalamus > hippocampus > frontal cortex, based on the BP ND values estimated (mean AE SD): 2.11 AE 0.43, 0.76 AE 0.3, 0.47 AE 0.3, and 0.29 AE 0.2, respectively, with cerebellum-hemispheres as the reference. The rank of the specific binding calculated from SRTM was identical to that calculated from LoganREF: striatum > thalamus > hippocampus > frontal cortex, with the BP ND values of 2.15 AE 0.46, 0.79 AE 0.3, 0.48 AE 0.2, and 0.32 AE 0.2 respectively. This rank of specific binding was consistent with the 2TCM method. In addition, the striatal BP ND values were estimated by SRTM and LoganREF using entire 120-min recordings and with truncation to 90, 60, 45 mins, to establish the time dependence of BP ND estimates (Table 5 ). The data indicated BP ND -SRTM values had no significant change when the scan duration for analysis was reduced from 120 min to 60 min. Meanwhile, BP ND -LoganREF values were impacted by the truncation of scan duration.
Correlations between modeling methods
To investigate the correlation of all seven modeling methods (2TCM, 1TCM, MA1, LoganAIF, RTM, SRTM, and LoganREF), Pearson's correlation tests were carried out using BP ND estimates of different brain regions from a total of three individual scans of three NHP subjects. The Pearson's coefficients (r) are summarized in Table 6A and the p-values are presented in Table 6B . Overall correlation data in Table 6 suggest that reference-based modeling methods had lower p-values and higher Pearson's coefficients (r). Regarding the correlation between modeling methods with arterial blood input and the methods based on reference, SRTM had the highest positive correlation with 2TCM (r = 0.958) with a p-value of 0.021 as displayed in The data from a blocking study using a vesicular acetylcholine transporter-specific inhibitor (À)-vesamicol (0.125 mg/kg) and one baseline data from the same monkey (subject A) were analyzed. The result showed partial blockade was achieve bỹ 54% and the V ND was~1.27, which was slightly lower than the V T value of cerebellar hemispheres. Table 6 and Fig. 5 (a), whereas RTM had less positive correlation with 2TCM (r = 0.940) with a p-value of 0.030 (Fig. 5b) . The LoganREF had the third highest positive correlation with 2TCM (r = 0.932) with a p-value of 0.034 as shown in Table 6 and Fig. 5(c) . The SRTM BP ND estimates indicated a strong correlation with those obtained from LoganREF with r = 0.994, p-value 0.003 as shown in Table 6 and Fig. 5(d) . Moreover, the BP ND estimates using LoganAIF were also in good agreement with those from LoganREF (r = 0.943, p-value 0.029), and LoganREF (r = 0.946, p = 0.027) with the cerebellum-hemispheres as reference region as shown in Table 6 . From these correlation results, we found that reference-based modeling including both SRTM and LoganREF were able to provide kinetics parameters similar to modeling with arterial blood input functions. However, when choosing the proper modeling method, it should be taken into consideration that BP ND values analyzed by reference-based modeling are always underestimated compared to 2TCM (2.1 vs. 3.4). This might partly be attributed to the inaccuracy in quantification in the low binding reference region cerebellar hemispheres.
Test-retest reproducibility
The reliability of [ 18 F]VAT PET measurement was demonstrated by a relatively low variability in repeated measurements of BP ND in the high-binding brain regions, including striatum, thalamus, frontal cortex and hippocampus, as shown in Table 7 . Global mean values of TRV% were less than 9%. Both TRVs using SRTM and LogaREF were comparable. For each outcome parameter, the mean of the test and retest scans, the TRV% (mean AE SD), and the ICC from either LoganREF or SRTM are summarized in Tables 7A and B VAT uptake was concordant with the expression levels of VAChT in different regions of the brain (Cyr et al. 2014; Petrou et al. 2014; Jin et al. 2016 a 2TCM was small, especially at baseline conditions shown in Table 2. 2TCM modeling provided good assessment of K 1 under both baseline conditions from three NHP subjects. At steadystate they are independent of tracer delivery and give an index of transport site density (Logan et al. 1994) . This view was supported by the observation that the rank order of V T values correlated well with the order of VAChT densities reported in both the rat and human brain post mortem (Cyr et al. 2014; Petrou et al. 2014; Jin et al. 2016 ) and the in vivo human studies using [ 18 F]FEOBV tracer (Petrou et al. 2014) .
All three NHP subjects with arterial blood input function examined using 2TCM-based methods gave similar estimates for V T and BP ND , and both parameters were estimated with high reproducibility. In addition, V T values estimated using the three methods including 2TCM, 1TCM, MA1, were highly correlated, but estimation with the LoganAIF led to a slightly low V T value. Incontrovertibly, the BP ND values from all these models were correlated even with the methods from the reference-based methods including RTM, SRTM, and LoganREF. Therefore, BP ND appeared to be a valuable parameter for assessing the level of VAChT because of the high level of precision that was not impacted by subject differences in blood flow or peripheral clearance.
Previous 
